What is HTAi?

HTAi is the global scientific and professional society for all those who produce, use, or encounter HTA. HTAi embraces all stakeholders, including researchers, agencies, policymakers, industry, academia, health service providers, and patients/consumers, and acts as a neutral forum for collaboration and the sharing of information and expertise. With members from 59 countries and six continents, HTAi is a thriving global network.

HTAi is actively committed to international collaboration, and has signed formal Memoranda of Understanding with the World Health Organization and the International Network of Agencies for HTA (INAHTA). From time to time, HTAi takes part in external initiatives in collaboration with other organizations. The Board of Directors may designate members to represent the society on external initiatives, and interested members encouraged to contact the HTAi Secretariat.

This website contains further information on membership and activities. Browse the top menu for a full overview of HTAi's work.

What is HTA?

HTA is a field of scientific research to inform policy and clinical decision-making around the introduction and diffusion of health technologies.

Health technologies include pharmaceuticals, devices, diagnostics and treatments, and other clinical, public health, and organizational interventions.

HTA is a multidisciplinary field that addresses the health impacts of technology, considering its specific healthcare context as well as available alternatives. Contextual factors addressed by HTA include economic, organizational, social, and ethical impacts. The scope and methods of HTA may be adapted to respond to the policy needs of a particular health system.

In health systems throughout the world, HTA plays an essential role in supporting decision-making about access to technology, its diffusion, and innovation.

Additional background on HTA is available through the International Network of Agencies for Health Technology Assessment (INAHTA).